2. Drug-receptor interactions. Dose-response relations, therapeutic concepts Flashcards

1
Q

At what threshold would the effect of a drug be seen?

A

When sufficient numbers of receptors are occupied we may see effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

The fraction of receptors in each state are dependent on…

A

Dissociation constant Kd

  • Concentration of ligand at which 50% of available receptors are occupied*
  • Lower Kd indicates a tighter drug-receptor interaction (high affinity)*
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Pharmacodynamics of a drug

A

Relationship between dose of drug and organism’s response to that drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Graded dose-response curve

A

Demonstrates effect of a drug as a function of its dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Max drug-receptor binding occurs when…

A

[LR] (cc of ligand-receptor complexes)

=

[Ro] (cc of receptors)

or [LR]/[Ro]=1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

EC50

A

Potency of drug (cc at which drug elicits 50% of its max effect)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Emax

A

Efficacy (max response produced by a drug)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Potency & efficacy relationship

A

Not intrinsically related, a drug can be extremely potent but have little efficacy & vice versa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Quantal dose-response relationship

A

Describes cc of a drug that produces a given effect in a population

  • Goal is to generalise a result to a population rather than examine grade of effect of different drug doses on a single individual
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

ED50

A

Dose that produces therapeutic response in 50% of population

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

TD50

A

Toxic dose in 50% of the population

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

LD50

A

Death in 50% of the population

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Agonist

A

Drugs that bind to its receptor and favour active receptor conformation

  • More potent drugs are those that have a higher affinity for their receptors
  • More efficacious drugs are those drugs that cause a higher proportion of receptors to be activated
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Partial agonist

A

Binds to a receptor at its active site but produces only a partial response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Because partial and full agonists bind to the same site on a receptor…

A

A partial agonist can reduce response produced by a full agonist

(Competetive agonist)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Inverse agonist

A
  • The receptor must have a basal level activity in the absence of any ligand
  • Decreases activity below basal level
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Antagonist

A

Drug that prevents activation of receptor by the agonist

  • Can bind to active/allosteric site of receptor for agonist
  • Reversible/irreversible
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Competetive antagonist

A

Reduces the potency of the agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Non-competitive antagonist

A

Reduces efficacy of agonist

20
Q

Chemical non-receptor antagonist

A

Inactivate an agonist before it has the opportunity to act, by chemical neutralisation

21
Q

Physiological non-receptor antagonist

A

Cause a physiological effect opposite to that induced by an agonist, by blocking or activating a receptor

22
Q

Therapeutic window

A

Range of doses of a drug that elicits a therapeutic response, without unacceptable adverse effects in a population

  • Can be quantified by therapeutic index
23
Q

Therapeutic index =

A

[LD50]/[ED50]

  • Provides a single number that quantifies the relatively safety margin
  • Large TI = Large/wide therapeutic window, TI = 10
  • Small TI = Small/narrow therapeutic window, TI = 5
24
Q

What is shown?

A

Continuous dose-response curve

25
What is shown?
Quantal dose-response curves ## Footnote *Effects on the population*
26
Affinity
The degree to which a drug tends to combine with a receptor
27
Efficacy
The desire to produce a successful result
28
Full agonist: Heroin and others
29
Partial agonist - Buprenorphine
30
Title the figure
Occupancy model
31
Title the figure
Two-state model
32
Full agonist
33
Partial agonist
34
Neutral antagonist
35
Inverse agonist
36
Give an example of inverse agonists
Antihistamines
37
Full agonist
38
Partial Agonist
39
Partial agonist
40
Examples of competitive antagonists
* Morphine * Benzodiazepines * MACh
41
Give example of noncompetitive antagonists
* Ketamine (on NDMA receptors)
42
When looking at a dose-response curve, a drug is not safe if...
The LD50 crosses with the ED50
43
Compare: 1. Which is more _potent_, butorphanol or morphine? 2. Which is more _effective_, butorphanol or morphine?
1. Butorphanol 2. Morphine
44
Full agonist: Efficacy + affinity
High efficacy + affinity
45
Full antagonist: Efficacy + affinity
High affinity; no efficacy
46
Partial agonist: Efficacy + affinity
High affinity; partial activation of receptor
47
Inverse agonist: Example
Antihistamine ## Footnote *Reverses the function of the agonist*